Benzonatate Capsules
DLA DIBBS (Defense Internet Bid Board)
Due Closes in 4 daysRef. SPE2DP-27-T-0438
At a glance
- What
BENZONATATE CAPSULES,USP, 100 MG, 100'S. 100 MILLIGRAMS OF BENZONATATE ACTIVE INGREDIENT.UNIT OF ISSUE: BOTTLE (BT) OF 100ea.
Category: 6505-00-660-1798
- Where
- DLA DIBBS (Defense Internet Bid Board)
- Key dates
- Posted: Nov 21, 2026
- Deadline: Wed, Nov 25, 2026 · 11:59 PM EST (closes in 4 days)
- How to respond
Submit through DLA DIBBS ↗ · how to bid
- Documents
- 1 document ↓
Description
BENZONATATE CAPSULES,USP, 100 MG, 100'S. 100 MILLIGRAMS OF BENZONATATE
ACTIVE INGREDIENT.UNIT OF ISSUE: BOTTLE (BT) OF 100ea. The capsules
should be protected from light, moisture and humidity, and stored at
controlled room temperature 20° to 25°C (68° to 77°F).
This device or drug is regulated by the FDA.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1
AVKARE LLC 4QGW8 P/N NDC42291-0091-01
GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC60429-0927-01
PROFICIENT RX LP 7GU24 P/N NDC71205-0885-00
NSN 6505-00-660-1798
Documents (1)
- Download📎 SPE2DP27T0438.PDFapplication/pdf · 470 KB
All notice detailsShow ↓
- Posted
- Nov 21, 2026
- Type
- RFQ
- Category
- 6505-00-660-1798
- Status
- open
- Jurisdiction
- DLA DIBBS (Defense Internet Bid Board)
- Reference #
- SPE2DP-27-T-0438
- Issued
- 11-20-2026
- Return By
- 11-25-2026
- Purchase Request
- 7019222061 QTY: 3
This listing is a summary from DLA DIBBS (Defense Internet Bid Board)'s open procurement data. The full solicitation documents are on the source portal.
Closes in 4 days🔔 Get alerts for bids like this